http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3699197-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_93611e4ceeb8402638b72d8846546b4d
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-622
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-31
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-283
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2878
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2809
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2803
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39541
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39558
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-3955
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39566
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2887
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-705
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
filingDate 2016-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e3e715db5cf1b2f56cddd43a7a738e09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_44bf978aa7122c87ba978c6c8c48ad77
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8381972f16ea7ae98653dfa74a58f0df
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_37bb8fbea4d97f47c38fb30ddc2bd648
publicationDate 2020-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-3699197-A1
titleOfInvention Trispecific antibody combining specific tumor targeting and local immune checkpoint inhibition
abstract The present invention relates to a novel molecule comprising three binding sites with specificity for a tumor cell, for an effector cell and for a checkpoint molecule, respectively. Moreover, the present invention relates to a pharmaceutical composition comprising such a molecule and to uses of such a molecule.
priorityDate 2015-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012251531-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412143
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21226086
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID155072714
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226474105
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11161
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5366546
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394003
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226504574
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65079
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69481
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID439075912
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226471481
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6207
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411806
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9568614
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4594
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409442

Total number of triples: 51.